Nuvalent, Inc. presents a perplexing valuation scenario. Despite a staggering market cap, the stock’s trading price has been significantly extended above its DCF value, suggesting a potential mispricing. The Forward P/E indicates optimism for future earnings, yet the negative Earnings Yield and high Price/Book ratio raise red flags about current profitability. The Altman Z-score, however, suggests financial stability, hinting at a low risk of bankruptcy. This juxtaposition of metrics paints a picture of a company with growth expectations but questionable current value.